e1 id: E33; e2 id: E106; e1 text: her tumor; e2 text: local and metastatic recurrence
ground truth: BEFORE; prediction: OVERLAP

e1 id: E36; e2 id: E107; e1 text: CMSAP; e2 text: dose reductions
ground truth: BEFORE; prediction: OVERLAP

e1 id: E34; e2 id: E106; e1 text: systemic chemotherapy; e2 text: local and metastatic recurrence
ground truth: OVERLAP; prediction: AFTER

e1 id: E123; e2 id: T1; e1 text: complaints; e2 text: 01/05/1994
ground truth: OVERLAP; prediction: BEFORE

e1 id: T11; e2 id: E108; e1 text: four cycles; e2 text: cycle 4
ground truth: BEFORE; prediction: OVERLAP

e1 id: E81; e2 id: E123; e1 text: fever; e2 text: complaints
ground truth: BEFORE; prediction: OVERLAP

e1 id: E84; e2 id: E93; e1 text: confusion; e2 text: admission
ground truth: BEFORE; prediction: OVERLAP

e1 id: E27; e2 id: E26; e1 text: 5.5 cm poorly differentiated infiltrating ductal and intraductal carcinoma; e2 text: The left simple mastectomy
ground truth: OVERLAP; prediction: BEFORE

e1 id: E1; e2 id: T1; e1 text: a metastatic adenocarcinoma of the breast; e2 text: 01/05/1994
ground truth: OVERLAP; prediction: BEFORE

e1 id: T15; e2 id: T0; e1 text: November; e2 text: May 1994
ground truth: BEFORE; prediction: AFTER

e1 id: E120; e2 id: T0; e1 text: her first course; e2 text: May 1994
ground truth: OVERLAP; prediction: AFTER

e1 id: E76; e2 id: E120; e1 text: some red cell transfusions; e2 text: her first course
ground truth: OVERLAP; prediction: AFTER

e1 id: T13; e2 id: T0; e1 text: mid May; e2 text: May 1994
ground truth: OVERLAP; prediction: AFTER

e1 id: E15; e2 id: E13; e1 text: Staging evaluation; e2 text: Fine needle aspiration
ground truth: OVERLAP; prediction: AFTER

e1 id: E13; e2 id: E10; e1 text: Fine needle aspiration; e2 text: mammography
ground truth: AFTER; prediction: OVERLAP

e1 id: E54; e2 id: E92; e1 text: chest wall nodules; e2 text: the Hem / Onc Clinic
ground truth: BEFORE; prediction: OVERLAP

e1 id: E56; e2 id: E57; e1 text: mediastinal recurrence; e2 text: bone scan
ground truth: BEFORE; prediction: OVERLAP

e1 id: E112; e2 id: E91; e1 text: viral pneumonitis; e2 text: The differential diagnosis
ground truth: OVERLAP; prediction: BEFORE

e1 id: E58; e2 id: E59; e1 text: head and liver CT; e2 text: metastatic disease
ground truth: OVERLAP; prediction: AFTER

e1 id: E4; e2 id: T3; e1 text: CCSS support; e2 text: June 1994
ground truth: BEFORE; prediction: OVERLAP

e1 id: E3; e2 id: E2; e1 text: PBSE; e2 text: high dose chemotherapy
ground truth: AFTER; prediction: OVERLAP

e1 id: E22; e2 id: E21; e1 text: a 5.5 cm poorly differentiated , Grade III out of III infiltrating ductal carcinoma; e2 text: The right modified radical mastectomy
ground truth: OVERLAP; prediction: BEFORE

e1 id: T0; e2 id: E0; e1 text: May 1994; e2 text: Admission
ground truth: BEFORE; prediction: OVERLAP

e1 id: E94; e2 id: E88; e1 text: presented; e2 text: admitted
ground truth: BEFORE; prediction: OVERLAP

e1 id: T5; e2 id: T4; e1 text: November 1990; e2 text: October 1991
ground truth: BEFORE; prediction: OVERLAP

e1 id: E88; e2 id: T1; e1 text: admitted; e2 text: 01/05/1994
ground truth: OVERLAP; prediction: BEFORE

e1 id: E50; e2 id: E109; e1 text: a pO2; e2 text: showed
ground truth: BEFORE; prediction: OVERLAP

e1 id: E49; e2 id: E45; e1 text: ABGs; e2 text: a flu-like illness
ground truth: OVERLAP; prediction: AFTER

e1 id: E60; e2 id: E63; e1 text: high dose chemotherapy; e2 text: Complications
ground truth: BEFORE; prediction: OVERLAP

e1 id: E124; e2 id: T1; e1 text: complaints; e2 text: 01/05/1994
ground truth: OVERLAP; prediction: BEFORE

e1 id: T12; e2 id: T8; e1 text: April 1993; e2 text: December 1993
ground truth: BEFORE; prediction: AFTER

e1 id: T3; e2 id: E87; e1 text: June 1994; e2 text: Discharge
ground truth: AFTER; prediction: OVERLAP

e1 id: T6; e2 id: T4; e1 text: October 1991; e2 text: October 1991
ground truth: OVERLAP; prediction: AFTER

